| Your MADRC Contacts |
|
Clinical Research Coordinators
Aviva Nathan, MPH
(734) 764-8445
Arijit Bhaumik, BA
(734) 936-8281
Education Core Coordinator
Cassie Starback, MSW
(734) 936-8764
Clinical Nurse Consultant
Edna Rose, Ph.D., MSW, RN, BC
(734) 936-8329 |
| MADRC Conference |
 |
Please join us for the 2009 MADRC Community Appreciation Conference, an informational event
for professionals and the interested public.
Conference Agenda
Please register online or by phone (734) 936-8764. |
| Public Policy Forum |
 |
MADRC representatives and invited guests were among the 500 Alzheimer's advocates who urged legislators to increase funding for dementia services and research at the 21st annual Alzheimer's Association Public Policy Forum. Please read about their experiences. |
| Edna Gates Conference |
|
MADRC is a proud sponsor of the 13th Edna Gates Conference: Creative Approaches to Life Enrichment in Dementia Care. MADRC-affiliated faculty, Drs. Hank Paulson, Judy Heidebrink and Bruno Giordani will be presenting in this year's conference.
Please save the date!
November 2 & 3, 2009
| |
|
Research Advances
Michigan Alzheimer's Disease Research Center
Spring / Summer 2009 |
|
From the Director
 Just as spring weather encourages the growth of new beginnings, the current call for grant renewal is spurring change and new direction for the MADRC. As we complete our 20th year of continuous NIH funding, our efforts toward a successful application for renewal will secure operation from June 2010 through May 2015. In compiling information for this grant, we are emphasizing previous progress and proposing new research initiatives and community activities. During the current grant period, the MADRC has made great progress in enhancing the understanding of the development of Alzheimer's disease from the molecular perspective as well as diagnostic accuracy using imaging techniques. The MADRC has also contributed to the role of drug development and evaluation for patients with Alzheimer's disease. We are participating in several ongoing medication trials and publications are on the horizon for new medications resulting in part from studies in the MADRC, such as Bapineuzumab.
MADRC accomplishments would not be possible without the commitment of our research volunteers. Individuals who participate in MADRC-supported studies have provided an invaluable contribution toward our understanding of Alzheimer's disease and related disorders. The MADRC will carry forward this momentum of knowledge by continuing to support exciting and innovative research projects during the new grant period.
Research highlights and future initiatives will be discussed at the MADRC Community Appreciation Conference: Advances in Prevention, Diagnosis, and Treatment of Alzheimer's Disease on October 1, 2009. We hope to see you there!
Sid Gilman, MD, FRCP
Director, MADRC |
Research at Michigan Toward a Cure for Alzheimer's
The search for better treatments for devastating neurodegenerative diseases like Alzheimer's is increasingly urgent. With more and more Americans living longer lives, the prevalence of neurodegenerative disease in the population is forecast to reach crisis proportions in coming decades. Nowhere is that challenge taken more seriously than at University of Michigan, where researchers at one of the nation's first Alzheimer's Disease Research Centers are seeking to better understand Alzheimer's and related dementias, such as Lewy body disease, frontotemporal and vascular dementias. Read more |
|
MADRC Studies 
Currently Enrolling
Brain Imaging -Researchers are now using brain scans to identify certain characteristic abnormalities in the brain that may signify that someone is more likely to develop Alzheimer's disease or to be able to detect the earliest brain changes that could occur before other clear symptoms might be recognized. These abnormalities or biological markers have begun to allow physicians to make a positive diagnosis with ever-increasing accuracy. Volunteer Form
Observational - MADRC researchers follow older adults over a period of time to observe specific changes, such as how an individual's health or memory may change over time. These studies do not require the participant to take any new drugs or medications. Vital information gathered from these types of studies have allowed researchers to gain new and valuable insights into Alzheimer's disease and other memory loss disorders. Volunteer Form
Clinical Drug Trials - Rapid advances in our knowledge about AD have led to the development of many experimental drugs and treatments. However, before these new treatments can be adopted, they must be shown to work in patients. More research is needed in order for scientists to develop treatment strategies aimed at finding a cure or a way to prevent AD altogether. Please contact Joanne Lord, Clinical Resesarch Coordinator, for more information on currently enrolling clinical drug trials - (734) 647-7760. Volunteer Form | |
|
The MADRC appreciates your time in reviewing these referral opportunities. Please do not hesitate to contact us for further information. We welcome you to forward this email to a colleague or friend.
Contact Information
Cassie Starback, MSW
Education Core Coordinator
2101 Commonwealth Blvd., Suite D.
Ann Arbor, MI 48105
|
|
|
